InsidersTradesSigma
Follow the Biotron Limited stock price and the full management transaction log of the company, a listed equity based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Biotron Limited has published 2 public disclosures. Market capitalisation: €5.6m. The latest transaction was reported on 18 August 2026 (Change in Substantial Holding). Among the most active insiders: There was a change in the interests of the. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 August 2026
Declarations2 total
ShareASXISIN AU000000BIT4ASX:2924-03122352-2A1690152
ShareASXISIN AU000000BIT4ASX:2924-03090484-2A1672245
2 of 2 declarations
关于 Biotron Limited
Biotron Limited 是一家澳大利亚生物制药公司，专注于开发病毒性疾病和免疫疾病的治疗方法。该公司在澳大利亚证券交易所 (XASX) 上市。
